First Fidelity Leasing Modaraba (PSX:FFLM)

Blueprint Medicines Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	-13.39	-22.75	-2.4	-6.22	-2.91	-4.65
Depreciation & Amortization	-4.8	0.04	0.09	0.28	0.21	0.19
Other Amortization	10.23	6.23	8.41	10.29	11.72	11.48
Loss (Gain) From Sale of Assets	-	-	-1.05	-1.96	-2.02	-0.98
Other Operating Activities	4.3	4.3	1.7	-2.63	0.22	-10.87
Change in Accounts Receivable	8.23	4.88	-9.43	5.69	-6.62	-7.85
Change in Other Net Operating Assets	8	1.22	1.85	-7.09	-4.07	9.3
Operating Cash Flow	16.71	1.89	0.16	-2.63	-0.72	-1.79
Operating Cash Flow Growth	272.83%	1083.82%	-	-	-	-
Capital Expenditures	-15.7	-	-	-0.1	-0.06	-0.13
Sale of Property, Plant & Equipment	-0.16	-	0	2.14	-	-
Other Investing Activities	-0.78	-	-	-	-	-
Investing Cash Flow	-16.64	-	0	2.04	-0.06	-0.13
Common Dividends Paid	-	-	-0.03	-0	-0.01	-0.08
Financing Cash Flow	-	-	-0.03	-0	-0.01	-0.08
Net Cash Flow	0.07	1.89	0.13	-0.59	-0.79	-1.99
Free Cash Flow	1.01	1.89	0.16	-2.73	-0.78	-1.91
Free Cash Flow Growth	-21.35%	1083.82%	-	-	-	-
Free Cash Flow Margin	9.62%	21.59%	0.93%	-13.13%	-3.55%	-9.40%
Free Cash Flow Per Share	0.04	0.07	0.01	-0.10	-0.03	-0.07
Cash Income Tax Paid	-	-0.02	0.65	-0.07	0	-1.37
Levered Free Cash Flow	-2.21	10.85	0.71	23.98	5.98	-1.81
Unlevered Free Cash Flow	-2.21	10.85	0.71	23.98	5.98	-1.81
Change in Net Working Capital	-11.8	-14.18	6.7	-14.74	2.99	8.19

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.